Overseas Investment News- China Business Network

Home > Overseas Investment News

Overseas Investment News

2021-03-11FinVolution Group Announces Dividend of US$ 0.17 per American Depositary Share for Fiscal Year 2020
2021-03-10Deeply integrating into global innovation network needs self-confidence in science and technology
2021-03-10Momo to Report Fourth Quarter and Full Year 2020 Results on March 25, 2021
2021-03-09FASN Inhibitor ASC40 Demonstrates Positive Phase 2 Topline Clinical Results from China Cohort of Patients with NASH
2021-03-09China Daily: Policy adviser: China to remain attractive to foreign investors
2021-03-08FactSet and Ping An to Offer Investors ESG Content and Analytics on Chinese Companies
2021-03-08Chongqing's Western Science City sets new policies on talents, innovation, industry and finance
2021-03-05Mercurity Fintech Holding Inc. Announced Changes to Board Composition
2021-03-05IMAX China Reports Full-Year 2020 Financial Results
2021-03-04Pingtan Marine Enterprise Ltd. Announces $4,750,000 Registered Direct Offering of Ordinary Shares and Warrants
2021-03-04ReTo Eco-Solutions Boosts Revenue Momentum with New RMB 10.71 Million Sales Contract
2021-03-03Biotheus Announces the Closing of a New Round of Financing co-led by General Atlantic and IDG Capital
2021-03-03SciClone Pharmaceuticals Officially Listed on the Main Board of the Hong Kong Stock Exchange
2021-03-03FinVolution Group to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Thursday, March 11, 2021
2021-03-02Zepp Health Corp. to Report Fourth Quarter and Full Year 2020 Financial Results on March 15, 2021
2021-03-02Cango Inc. Announces Up to US$50 Million Share Repurchase Program
2021-03-01Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index
2021-03-01Everest Medicines Announces Selection as a Constituent of Certain Indexes of Hang Seng Indexes Company Limited
2021-02-26AmCham South China: 94% of US Companies Optimistic towards 2021 Business Outlook in China
2021-02-26Harbour BioMed Announces NMPA Approval of IND for Combination Therapy of Next Gen Anti-CTLA-4 Antibody for Treatment of NSCLC and Solid Tumors

First　Previous　1 2 3 4 5　Next　Last　Total 2327 20/Page Page 2 of 117 Go To: